Muscular Dystrophy Clinical Trials 2024

Muscular Dystrophy Clinical Trials 2024

Muscular Dystrophy research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in muscular dystrophy clinical trials today.

Muscular Dystrophy Clinical Trials

Here are the 6 most popular medical studies for muscular dystrophy

Popular filter options for muscular dystrophy trials

Duchenne Muscular Dystrophy Clinical Trials

View 49 Duchenne Muscular Dystrophy medical studies.

DMD Clinical Trials

View 49 DMD medical studies.

DMD Positive Clinical Trials

View 7 DMD positive medical studies.

Phase 3 Muscular Dystrophy Clinical Trials

View 82 phase 3 muscular dystrophy medical studies.

Muscular Dystrophy Clinical Trials With No Placebo

View 82 muscular dystrophy medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to muscular dystrophy

What are the top hospitals conducting muscular dystrophy research?

In the quest to find effective treatments for muscular dystrophy, several leading hospitals are paving the way through their cutting-edge clinical trials. Nationwide Children's Hospital in Columbus takes the forefront with an impressive 13 ongoing trials addressing this debilitating condition, building upon their extensive history of 38 previously conducted studies. Their commitment to research began in 2009 when they recorded their first muscular dystrophy trial. Meanwhile, the University of Florida in Gainesville is making significant strides as well, currently conducting eight active clinical trials and having completed a total of 19 studies dedicated to muscular dystrophy since their inaugural trial also in 2009.

Moving on to Baltimore's Kennedy Krieger Institute, researchers there are actively involved in eight clinical trials focused on discovering breakthroughs for muscular dystrophy patients. With a history encompassing 19 previous investigations since initiating their first trial in 2014, this institute is dedicated to improving outcomes and quality of life for those affected by this genetic disorder.

Additionally contributing to these efforts is Arkansas Children's Hospital located in Little Rock where seven ongoing muscular dystrophy trials highlight their dedication towards finding potential solutions. Although it may seem relatively recent compared to other institutions' involvement, Arkansas Children's Hospital has made notable progress since recording its first trial merely three years ago -in2018-while completing eleven prior studies thus far.

Lastly,the University of Kansas Medical Center situated within Kansas City rounds off our list with seven active clinical trials targeting muscular dystrophy while boasting an admirable count of twenty-three completed investigations overall; such contributions initiated almost twelve years back,since recording its pioneering examination took place-way back-in2009.

These hospitals represent beacons of hope for individuals living with muscular dystrophy and demonstrate the tireless efforts being made globally towards combatting this complex disease. Each study undertaken brings us closer to understanding more about this condition while offering promising prospects for improved treatments that could transform countless lives worldwide

Which are the best cities for muscular dystrophy clinical trials?

When it comes to muscular dystrophy clinical trials, several cities emerge as leading locations for research and advancement. Los Angeles, California tops the list with 30 ongoing trials exploring treatments like Cohort 1, PF-06939926, and Pamrevlumab. Salt Lake City, Utah closely follows with 27 active studies focused on interventions such as PF-06939926, Cohort 1, and Losmapimod. Columbus, Ohio is also a prominent hub for muscular dystrophy research with 16 ongoing trials investigating therapies like Losmapimod and SRP-9003. These cities offer individuals affected by muscular dystrophy access to cutting-edge clinical trials that pave the way for improved care and potential breakthroughs in treatment options.

Which are the top treatments for muscular dystrophy being explored in clinical trials?

Muscular dystrophy continues to be an area of active exploration in clinical trials, with several promising treatments emerging. Leading the charge is PF-06939926, currently being tested in two ongoing trials for muscular dystrophy. Another contender is pamrevlumab, also involved in two active studies and showing promise since its listing in 2016. Last but not least is eteplirsen, which has gained attention with its involvement in two current trials and a total of five all-time muscular dystrophy trials since 2014. These treatments offer hope for patients as researchers strive towards finding effective solutions for this debilitating condition.

What are the most recent clinical trials for muscular dystrophy?

Promising advancements are being made in the realm of muscular dystrophy research, with recent clinical trials offering hope and potential breakthroughs. Notably, NS-089/NCNP-02 has entered Phase 2 trials as a potential treatment option for individuals with muscular dystrophy. Similarly, BBP-418 and delandistrogene moxeparvovec have both advanced to Phase 3 trials—a significant milestone that brings us closer to effective therapies for this condition. Additionally, SRP-6004 is currently undergoing Phase 1 testing, while AOC 1020 Regimen 1 shows promise through its combined Phase 1 and Phase 2 study design. These ongoing clinical trials hold immense promise for patients grappling with muscular dystrophy and offer renewed optimism in their pursuit of improved quality of life.

What muscular dystrophy clinical trials were recently completed?

Several significant clinical trials for muscular dystrophy have recently reached completion, providing important insights into potential treatments. In December 2021, PTC Therapeutics concluded its trial investigating the efficacy of Ataluren in addressing this debilitating condition. Similarly, NS Pharma successfully completed a trial for Viltolarsen in July 2021. While not as recent, Northwestern University's Prednisone study wrapped up in July 2019 and also contributed valuable information to the field of muscular dystrophy research. These milestones demonstrate ongoing efforts to find effective therapies for individuals living with this challenging disorder.